Ibuprofen 200 mg Tablets
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 3 recall · DMRC- 38319360
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Ibuprofen 200 mg Tablets | PL: 08977/0016 | ibuprofen | 5010441006481 |
Background: Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters. The investigation confirmed that other batches were not impacted since the issue is related to a specific batch of aluminium foil utilised for these four batches of tablets. These products are Pharmacy (P) medicines and can only be sold or dispensed from a registered pharmacy premises by a pharmacist, or by staff acting under their direct supervision. Advice for Healthcare Professionals: Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.